Skip to main content

Brain Angiotensin and Cardiovascular Reactivity to Negative and Positive Emotional Stress

Buy Article:

$68.00 + tax (Refund Policy)

Cardiovascular reactivity, an abrupt increase in blood pressure and heart rate in response to negative emotional stress is a risk factor for hypertension and heart disease. Brain angiotensin II (Ang II) has been recognized as an important regulator of cardiovascular reactivity. Apart from threatening events, exposure to appetitive stimuli is capable of inducing a distinct, sympathetically mediated rise in blood pressure in both animals and humans. Recent animal studies employing microinjection of AT1 receptor antagonists directly into hypothalamic and brainstem nuclei indicate that locally released AngII acts to facilitate, through a superoxide-dependent mechanism, the pressor response to negative stress. Conversely, animal studies demonstrated that brain Ang II is less important in the regulation of cardiovascular arousal associated with positively motivated behavior, such as anticipation and consumption of palatable food. Thus, endogenous AngII in the brain appears to control the activation of central pathways primarily associated with the defense response, rather than nonspecifically modulating cardiovascular reactivity regardless of emotional valence (attraction or aversion) of stimuli. These findings may be of clinical importance as they suggest that targeted inhibition of Ang II -superoxide signaling in the brain may selectively reduce blood pressure reactivity to negative emotional stress, without affecting cardiovascular arousal associated with normal daily activities.





Keywords: Angiotensin; blood pressure; brain; stress; superoxide; sympathetic

Document Type: Research Article

Affiliations: Baker Heart Research Institute,PO Box 6492, St. Kilda Rd. Central, Melbourne, Victoria 8008, Australia.

Publication date: 01 May 2007

More about this publication?
  • Current Hypertension Reviews publishes frontier reviews on all the latest advances on hypertension and its related areas e.g. nephrology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians and researchers in the field of hypertension.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content